Yantai Dongcheng Pharmaceutical GroupLtd Dividends and Buybacks
Dividend criteria checks 2/6
Yantai Dongcheng Pharmaceutical GroupLtd is a dividend paying company with a current yield of 0.82%.
Key information
0.8%
Dividend yield
-6.8%
Buyback Yield
| Total Shareholder Yield | -6.0% |
| Future Dividend Yield | 2.0% |
| Dividend Growth | 9.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.100 |
| Payout ratio | 159% |
Recent dividend and buyback updates
Recent updates
Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) Takes On Some Risk With Its Use Of Debt
Dec 19
Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) Has A Pretty Healthy Balance Sheet
Aug 23Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s (SZSE:002675) Business Is Yet to Catch Up With Its Share Price
Jul 12News Flash: 7 Analysts Think Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SZSE:002675) Earnings Are Under Threat
May 06Yantai Dongcheng Pharmaceutical GroupLtd's (SZSE:002675) Problems Go Beyond Weak Profit
May 05Is Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) A Risky Investment?
Mar 15Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s (SZSE:002675) P/E Is On The Mark
Feb 27Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 002675's dividend payments have been volatile in the past 10 years.
Growing Dividend: 002675's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Yantai Dongcheng Pharmaceutical GroupLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (002675) | 0.8% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Biotechs) | 1.3% |
| Analyst forecast (002675) (up to 3 years) | 2.0% |
Notable Dividend: 002675's dividend (0.82%) is higher than the bottom 25% of dividend payers in the CN market (0.58%).
High Dividend: 002675's dividend (0.82%) is low compared to the top 25% of dividend payers in the CN market (2.19%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (158.9%), 002675's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 002675 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 02:40 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yanyin Zhu | China International Capital Corporation Limited |
| Zhu Chen | Citic Securities Co., Ltd. |
| Xiao Wei Lin | Everbright Securities Co. Ltd. |